Abstract
Background: There is an inherent risk of overestimating the risk of coexisting invasive disease in patients with DCIS on a diagnostic core needle biopsy. This results in a potential escalation of surgical intervention with the introduction of a diagnostic SLNB for the synchronous staging of the axilla which may result in additional morbidity. Patients with pure low-grade DCIS (LG DCIS) do not benefit from SLNB at the time of their primary surgery as the incidence of upgrade to microinvasion/ invasion is very low.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
